This white paper examines how artificial intelligence can help life sciences companies manage increasingly complex global transparency reporting requirements. Compliance teams must navigate fragmented regulations, inconsistent data, privacy obligations, siloed systems, legacy technology, and limited resources. AI can act as an operational force multiplier by automating repetitive tasks, improving data quality, monitoring risks, and supporting faster, more proactive decisions. Agentic AI may further streamline workflows and identify emerging issues, but its use requires clear governance, traceable outputs, strong data foundations, human oversight, and defensible decision-making.

Join for free to read